Tarceva approved in Europe for genetically distinct type of lung cancer

Tarceva is indicated for the first-line treatment of patients with locally advanced or metastatic...
Read more

Date: 2011-09-16 14:00:00
Related topics : locally advanced non small cell lung cancer / non small cell lung cancer treatment / small cell lung cancer treatments